Which hedge funds own CRBP? CORBUS PHARMACEUTICALS HLDGS, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in CRBP (CORBUS PHARMACEUTICALS HLDGS) in their Q2 2026 13F filings, worth $3.0m in total. The largest holder by portfolio weight is Brevan Howard Capital Management at 0.0% of its book. 2 exited: D. E. Shaw & Co, Point72 Asset Management LP.
6tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold CRBP? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $210.8k | 22,477 | -31% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.0m | 110,822 | -68% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $744.1k | 79,331 | -46% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $864.4k | 92,154 | -87% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $107.3k | 11,438 | -89% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $600 | 64 | 0% | held |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| D. E. Shaw & Co | 0.0% | $248.6k |
| Point72 Asset Management LP | 0.0% | $481.7k |
How has hedge fund ownership of CRBP changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $3.0m |
| Q1 2026 | 8 | $13.5m |
| Q4 2025 | 3 | $3.5m |
| Q3 2025 | 2 | $1.4m |
| Q2 2025 | 1 | $1.1m |
| Q1 2025 | 1 | $1.8m |
| Q4 2024 | 1 | $1.6m |
| Q3 2024 | 1 | $330.1k |
| Q2 2024 | 3 | $30.8m |
| Q1 2024 | 3 | $29.5m |
| Q4 2022 | 1 | $11.0k |
| Q3 2022 | 1 | $130.0k |
| Q2 2022 | 1 | $410.0k |
| Q1 2022 | 1 | $615.0k |
| Q4 2021 | 1 | $151.0k |
| Q4 2020 | 1 | $1.2m |
Counts every tracked manager that disclosed CRBP in that quarter's filing, including managers that have since stopped filing.